
Luisa Mestroni MD FACC, FAHA, FESC
Heart Failure & Transplantation, Exercise Physiology and Cardiac Rehabilitation
Professor, Medicine, University of Colorado School of Medicine
Join to view full profile
12700 E 19th AveAurora, CO 80045
Phone+1 303-906-9132
Dr. Mestroni is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Luisa Mestroni is a cardiologist based in Aurora, CO, with subspecialties in heart failure and cardiovascular genetics. Her expertise encompasses general cardiology, electrocardiography, cardiomyopathies, left ventricular dysfunction, and cardiac genetics. She has contributed multiple publications to prestigious high-impact journals, including New England Journal of Medicine, Lancet, Circulation and the European Heart Journal, on topics such as myocardial recovery and arrhythmogenic risk scores. She has participated in clinical trials, notably on Valsartan for early sarcomeric HCM and gene therapy. Dr. Mestroni has received numerous certifications from Epic Systems Corporation for CMS Meaningful Use and is recognized as a Fellow by both the American Heart Association and the American College of Cardiology.
Education & Training
Università degli Studi di TriesteClass of 1979
Certifications & Licensure
CO State Medical License 1999 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- Fellow American Heart Association, 2006
Clinical Trials
- Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.Peter Orchard, Thomas W Blackwell, Linda Kachuri, Peter J Castaldi, Michael H Cho
Science. 2026-07-16 - Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry.Maria Perotto, Cinzia Radesich, Alessia Paldino, Ilaria Gandin, Job A J Verdonschot
Circulation. Genomic and Precision Medicine. 2026-07-08 - 1 citationsSex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry.Sophie L V M Stroeks, Nicole K Bart, Joseph Rossano, Brian Claggett, Nina J Beelen
Journal of the American College of Cardiology. 2026-06-30
Press Mentions
Novel Model May Predict Arrhythmic Risk in FLNCtv Carriers, Assist Decision of Prophylactic ICD Implantation: JAMAFebruary 14th, 2025
What’s in Your Genes? What This Mom Learned After Donating One Vial of Blood to the BiobankJanuary 13th, 2025
Researchers Find Association Between Gene Mutation and Rare Heart DiseaseNovember 15th, 2016
Grant Support
- Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic TargetsUNIVERSITY OF COLORADO DENVER2023–2028
- Elucidating the Origin of Sudden Cardiac Death in Dilated Cardiomyopathy: from Phenotype Predictors to Therapeutic TargetsUNIVERSITY OF COLORADO DENVER2023–2028
- Cardiomyocyte phenotype and mechanotransduction in Filamin C gene variants causing arrhythmogenic cardiomyopathyUNIVERSITY OF COLORADO DENVER2020–2024
- The Familial Cardiomyopathy RegistryNational Center For Research Resources2007–2008
- Molecular Epidemiology Of Dilated CardiomyopathNational Heart, Lung, And Blood Institute2002–2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









